3CGO | pdb_00003cgo

IRAK-4 Inhibitors (Part II)- A structure based assessment of imidazo[1,2 a]pyridine binding


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.00 Å
  • R-Value Free: 
    0.318 (Depositor), 0.300 (DCC) 
  • R-Value Work: 
    0.243 (Depositor), 0.218 (DCC) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 3CGO

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

IRAK-4 inhibitors. Part II: A structure-based assessment of imidazo[1,2-a]pyridine binding

Buckley, G.M.Ceska, T.A.Fraser, J.L.Gowers, L.Groom, C.R.Higueruelo, A.P.Jenkins, K.Mack, S.R.Morgan, T.Parry, D.M.Pitt, W.R.Rausch, O.Richard, M.D.Sabin, V.

(2008) Bioorg Med Chem Lett 18: 3291-3295

  • DOI: https://doi.org/10.1016/j.bmcl.2008.04.039
  • Primary Citation Related Structures: 
    3CGF, 3CGO

  • PubMed Abstract: 

    A potent IRAK-4 inhibitor was identified through routine project cross screening. The binding mode was inferred using a combination of in silico docking into an IRAK-4 homology model, surrogate crystal structure analysis and chemical analogue SAR.


  • Organizational Affiliation
    • UCB, Granta Park, Great Abington, Cambridge CB21 6GS, UK.

Macromolecule Content 

  • Total Structure Weight: 42.48 kDa 
  • Atom Count: 2,784 
  • Modeled Residue Count: 332 
  • Deposited Residue Count: 365 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Mitogen-activated protein kinase 10365Homo sapiensMutation(s): 0 
Gene Names: MAPK10JNK3JNK3APRKM10
EC: 2.7.11.24
UniProt & NIH Common Fund Data Resources
Find proteins for P53779 (Homo sapiens)
Explore P53779 
Go to UniProtKB:  P53779
PHAROS:  P53779
GTEx:  ENSG00000109339 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP53779
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
JNO

Query on JNO



Download:Ideal Coordinates CCD File
B [auth A]2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide
C19 H23 N7 O
AJLILYAPRHIFAS-UHFFFAOYSA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
JNO BindingDB:  3CGO IC50: 270 (nM) from 1 assay(s)

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.00 Å
  • R-Value Free:  0.318 (Depositor), 0.300 (DCC) 
  • R-Value Work:  0.243 (Depositor), 0.218 (DCC) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 52.22α = 90
b = 71.77β = 90
c = 107.72γ = 90
Software Package:
Software NamePurpose
CNXrefinement
DENZOdata reduction
SCALEPACKdata scaling
CNXphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2008-06-03
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Version format compliance
  • Version 1.2: 2017-10-25
    Changes: Refinement description
  • Version 1.3: 2023-11-01
    Changes: Data collection, Database references, Derived calculations, Refinement description